Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/07/2003CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003CA2480126A1 Cell culture medium for lymphoid cells
08/07/2003CA2474968A1 Cryopreservation medium for primate embryo stem cells and cryopreservation method
08/07/2003CA2474960A1 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
08/07/2003CA2474954A1 Treatment of tumor cells for use in immunotherapy of cancer
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003CA2474777A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003CA2474759A1 Gene for peripheral arterial occlusive disease
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003CA2474571A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474497A1 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003CA2474339A1 Multiple virus replicon culture systems
08/07/2003CA2473810A1 Fgfr agonists
08/07/2003CA2473360A1 Serum-free media for chondrocytes and methods of use thereof
08/07/2003CA2473353A1 Adult human olfactory stem cell
08/07/2003CA2470195A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
08/07/2003CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003CA2463476A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2438112A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1333086A1 Cell culture case
08/06/2003EP1333035A2 Growth differentiation factor-8
08/06/2003EP1332761A1 Agonists of fibroblast growth factor receptors (FGFR)
08/06/2003EP1332760A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/06/2003EP1332673A1 Method of controlling proliferation and differentiation of stem and progenitor cells
08/06/2003EP1332371A2 Method to identify antibody targets based on mass spectrometry (maldi-tof)
08/06/2003EP1332218A1 Differentiation-inducing substances
08/06/2003EP1332217A2 Novel bacterial phytases and method for producing same
08/06/2003EP1332216A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
08/06/2003EP1332209A2 Collections of repeat proteins comprising repeat modules
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
08/06/2003EP1332153A1 Human ect2 and methods of use
08/06/2003EP1331950A1 Methods and compositions for nucleic acid delivery
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1276431A4 Method for expansion of epithelial stem cells
08/06/2003EP1241933A4 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight
08/06/2003EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds
08/06/2003EP1015570A4 Fibrin microbeads and uses thereof
08/06/2003EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
08/06/2003EP0880358B1 Inhibitors of cyclophilin rotamase activity
08/06/2003EP0791076A4 Diagnostic method and kit for determining kell blood group genotype
08/06/2003CN1434923A Conformational and topolodical protein regulation
08/06/2003CN1434921A T2R taste receptors and genes encoding same
08/06/2003CN1434869A Root-specific promoter
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434719A Preparation capable of mobilization of activity
08/06/2003CN1434679A High temperature cryogenic preservation of biolcally active material
08/06/2003CN1434123A Method for producing tripterygium alkaloids by plant suspension cultivation cell
08/06/2003CN1434119A Establishment and use of adult stem cell restitution hemopoiesis method of mesenchyme stem cell phynotype
08/06/2003CN1117155C Novel compounds
08/06/2003CN1117151C Riboflavin synthesis in fungi
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections
08/05/2003US6603065 Transformation of hereditary material of plants
08/05/2003US6603062 Introducing into monocotyledons nucleic acid molecules encoding a enzyme isolated from purple bacteria;
08/05/2003US6603061 Agrobacterium-mediated plant transformation method
08/05/2003US6603060 Method for regulating cell death
08/05/2003US6603059 Method of cloning animals
08/05/2003US6603057 Disruption in genomic DNA fragment; tumorigenesis and propensity to ulcerative colitis; replacement with a neomycin gene under the control of phospholipid kinase; use in prevention and treatment of tumors; drug screening
08/05/2003US6602975 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
08/05/2003US6602857 Antisense modulation of PTP1B expression
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602850 Method of treating asthma using soluble IL-9 receptor variants
08/05/2003US6602711 Removing the adhering colonies from the substrate in clumps; incubating in a container and allowing them to coalesce; useful for drug discovery, toxicity screens, and will provide a source of cells for transplantations
08/05/2003US6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
08/05/2003US6602708 Enhancing replication of neural cells with an immortalizing
08/05/2003US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid
08/05/2003US6602706 Cell comprising nucleotide sequence encoding viral gene product and recombinant nucleic acids lacking overlapping sequences; virus unable to replicate; use in treatment of genetic disorders and autoimmune diseases; antitumor agent
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602686 Compositions and method for non-targeted activation of endogenous genes
08/05/2003US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602681 Reacting enzyme, of given amino acid sequence, produced by a recombinant DNA technique from Xenopus laevis
08/05/2003US6602680 Production of gabaergic cells
08/05/2003US6602677 Thermostable luciferases and methods of production
08/05/2003US6602672 Nucleic acid sequence; assay for distinguishing between conformational shapes and isolating infectious and noninfectious prions; neurodegenerative diseases; transgenic animals
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003US6602296 Chemical supplementation of bone
08/05/2003CA2202549C Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene
07/2003
07/31/2003WO2003062867A2 Methods and apparatus for generating and utilizing linear moving optical gradients
07/31/2003WO2003062467A2 Tissue rejection
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062432A1 Method for increasing the efficiency of an inhibitor of tyrosine kinase activity
07/31/2003WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor
07/31/2003WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof
07/31/2003WO2003062423A2 Method for inhibiting the expression of a target gene resulting from a chromosome aberration
07/31/2003WO2003062419A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities
07/31/2003WO2003062414A2 Methods of obtaining isoform specific expression in mammalian cells
07/31/2003WO2003062405A2 Method for inducing differentiation of embryonic stem cells
07/31/2003WO2003062404A1 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby